Activity on cognitive performance

Naturex supported a randomized, double-blind, placebo-controlled, and crossover study to determine whether CereboostTM improves cognitive performance in healthy individuals.
The clinical trial was conducted by Prof. Andrew Scholey at the NICM Centre for the Study of Natural Medicines and Neurocognition, Brain Sciences Institute, Swinburne University, Melbourne, Australia.
The COMPASS (Computerised Mental Performance Assessment System) battery was designed to test sensitivity to CereboostTM. The tasks in this study allowed us to assess across the major cognitive domains-i.e., attention/concentration, working memory, secondary memory, and executive function.  


CereboostTM demonstrated significant acute and positive impact on the following cognitive areas:
- Attention
- Working Memory
- Secondary Memory